Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Jan 27 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Jan 26 2023

Is US Hemp Policy Heading For Farm Bill, Act III?

Jan 27 2023

NPA Petitions US FDA To Act On CBD Regulation

Feb 23 2022

US VMS Industry Makes Lame Duck Session List, Checks It Twice For MPL Language

Dec 06 2022

HBW Market News: CHPA Petitions For CBD Reg, PEW Urges Stronger Supplement Oversight

Nov 15 2019

‘Time Is Now’ For FDA Rule On Lawful CBD Use In Supplements, CRN Says In Citizen Petition

Jun 17 2020

Additional Topics

International United States US States Cannabidiol CBD FDA Legislation Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Dietary Supplements Cosmetics Enforcement Ingredients Manufacturing OTC Drugs Policy Politics Retail Safety

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window